Meinuo Hua plans to raise up to 2.109 billion yuan through a private placement of shares. The funds will be allocated to projects including a global industrial base for high-end oral solid preparations and complex injections, as well as an R&D initiative for high-activity and poorly soluble drugs. A portion of the capital will also be used to supplement working capital. AI
IMPACT This funding will support R&D in advanced drug formulations, potentially leading to new therapeutic options.
RANK_REASON Company funding round announcement. [lever_c_demoted from significant: ic=1 ai=0.4]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →